Authors: Carminda P. Rogacion, MD, Emmanuel C. Perez, MD, MPH, FPFCP, FPRA, Johannes F. Dayrit, MD, FPDS
Introduction: Behçet’s disease is a chronic multisystem disease that is characterized by vasculitis. Recurrent oral aphthous ulcers, genital ulcers, skin and ocular lesions, and arthritis are the most frequent clinical manifestations. Pathergy may or may not be present. Due to its distinct clinical presentation, knowledge and clinical expertise are needed in order to promptly establish the diagnosis and address the disease. We report two cases of Behcet’s Disease in 2 Filipinos on the basis of history, clinical presentation, and supported by skin punch biopsy findings.
Case Summary: We encountered two patients with Behcet’s disease. Both presented with recurrent oral ulcers and genital ulcers with papulopustules. Case 1 is a 27-year old male who presented with recurrent vasculitis on the lower leg, nodular acne and recurrent apthous ulcers. Skin punch biopsies on a papule and on a purpuric patch showed perivascular and periadnexal inflammatory infiltrate of lymphocytes and neutrophils. Referral to rheumatology confirmed the diagnosis of Behcet’s disease. Case 2 is a 37-year old female, who presented with reccurent oral ulcers, genital ulcers, papustules on the face, nodules on lower extremities, and arthritis. Skin punch biopsies were done on a pustule and a nodule, showing perivascular dermatitis with neutrophils, and lobular panniculitis, respectively. A referral to rheumatology confirmed the diagnosis of Behcet’s disease. Both patients were initially given low doses of oral glucocorticoids. The first patient was given Dapsone 100mg once a day. The second patient was given Colchicine 500mcg once a day. Both patients were noted to have resolution of lesions while under maintenance therapy for several months.
Conclusion: Diagnosis of Behcet’s Disease is made clinically. Pathergy test and skin punch biopsy, though non-specific, support the diagnosis. The clinician must be aware of the constellation of symptoms that characterize the disease since treatment is specific to the clinical features of each patient. This will also prevent systemic complications associated with the disease.
Rogacion C, Perez E, Dayrit J. Behcet’s disease in 2 Filipinos: a case report. J Phil Dermatol Soc. 2018; 27(2): 74-9.
Hemochromatosis, Hereditary Hemochromatosis, Secondary Hemochromatosis, Iron overload disease, HFE gene, Iron.
2. Fereydoun Davatchi, Cheyda Chams-davatchi, Hormoz Shams, Farhad Shahram, Abdolhadi Nadji, Massoomeh Akhlaghi, Tahreh Faezi, Zahra Ghodsi, Bahar Sadeghi Abdollahi, Farimah Ashofteh, Negin Mohtasham, Hoda Kavosi & Mariam Masoumi (2016): Behcet’s Disease: Epidemiology, Clinical Manifestations, and Diagnosis, Expert Review of Clinical Immunology, DOI: 10.1080/1744666X.2016.1205486
3. Tursen U, Gurler A, Boyvat A. Evaluation of clinical findings according to sex in 2313 Turkish patients with Behçet’s disease. Int J Dermatol. 2003; 42: 346-351.
4. Gürler A, Boyvat A, Türsen U. Clinical manifestations of Behçet’s disease: an analysis of 2147 patients. Yonsei Med J. 1997; 38: 423-427.
5. Azizlerli G, Köse AA, Sarica R, Gül A, Tutkun IT. Prevalence of Behçet’s disease in Istanbul, Turkey. Int J Dermatol. 2003; 42: 803-806.
6. Hamuryudan V., Kötter I. (2010) Medical Management of Behçet’s Syndrome. In: Yazıcı Y., Yazıcı H. (eds) Behçet’s Syndrome. Springer, New York, NY
7. Alpsoy, E. New evidence-based treatment approach in Behçet’s disease. Pathol Res Int 2012;2012:871019.
8. E. Aktulga, M. Altac, and A.Muftuoglu, “A double blind study of colchicine in Behcet’s disease,” Haematologica, vol. 65, no.3, pp. 399– 402, 1980
9. S. Yurdakul, C. Mat, Y. Tuzun et al., “A double-blind trial of colchicine in Behcet’s syndrome,” Arthritis and Rheumatism, vol. 44, no. 11, pp. 2686–2692, 2001.
10. K. E. Sharquie, R. A. Najim, and A. R. Abu-Raghif, “Dapsone in Behcet’s disease: a double-blind, placebo-controlled, crossover study,” Journal of Dermatology, vol. 29, no. 5, pp. 267–279, 2002.
11. Lynde CB, Bruce AJ, Rogers RS. Successful Treatment of Complex Aphthosis With Colchicine and Dapsone. Arch Dermatol. 2009;145(3):273–276. doi:10.1001/archdermatol.2008.591
Authors: Katrina Carmela M. Belen, MD, DPDS, Jasmin J.Jamora, MD, FPDS , Ma. Cecilia P. Ingente MD, DPDSAbstractBackground: Dermoscopy, a non-invasive diagnostic tool, has been proven to improve the diagnostic accuracy of vascular tumors since it can aid in...
A randomized, double-blind, comparative study on the safety and efficacy of virgin coconut (Cocos nucifera l.) oil against 1% hydrocortisone lotion as an anti-inflammatory and antipruritic preparation for mosquito reactions
Authors: Uy, Veronica S, MD; Gracia B. Teodosio, MD, FPDS; Ma. Teresita G. Gabriel, MD, FPDS; Mary Catherine T. Galang, MD; Mohammad Yoga A. Waskito, MD; Johannes F. Dayrit, MD, FPDS Abstract Background: Virgin coconut oil (VCO) has been reported...
Primary Cutaneous Anaplastic Large Cell Lymphoma (PC-ALCL) is a rare Non-Hodgkin lymphoma (NHL) representing approximately 9% of all cutaneous lymphomas.3 It usually manifests as a slow-growing, solitary tumor which has a tendency to regress spontaneously. However, metastasis is reported in 5-10% of cases.